Current ways of treating dyslipidemias to prevent atherosclerosis.

about

Preclinical and Clinical Studies on Antioxidative, Antihypertensive and Cardioprotective Effect of Marine Proteins and Peptides-A Review

P2860

Q28067396-8496ABE5-7C98-42D5-AFD3-FA580BDA7AC4

P2860

Current ways of treating dyslipidemias to prevent atherosclerosis.

Item

http://www.wikidata.org/entity/Q43812794

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Current ways of treating dyslipidemias to prevent atherosclerosis.

@en

Current ways of treating dyslipidemias to prevent atherosclerosis.

@nl

type

Item

label

Current ways of treating dyslipidemias to prevent atherosclerosis.

@en

Current ways of treating dyslipidemias to prevent atherosclerosis.

@nl

prefLabel

Current ways of treating dyslipidemias to prevent atherosclerosis.

@en

Current ways of treating dyslipidemias to prevent atherosclerosis.

@nl

P1476

Current ways of treating dyslipidemias to prevent atherosclerosis

@en

P2093

Francesco Angelico

http://www.w3.org/2001/XMLSchema#string

Maria Del Ben

http://www.w3.org/2001/XMLSchema#string

P2860

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association

Simvastatin with or without ezetimibe in familial hypercholesterolemia

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

P304

125-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1111/J.1744-9987.2012.01114.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Baratta

P577

2012-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236102649

http://www.w3.org/2001/XMLSchema#string

P698

23551668

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

dyslipidemias

Current ways of treating dyslipidemias to prevent atherosclerosis.

about

P2860

P2860

Current ways of treating dyslipidemias to prevent atherosclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921